Skip to content

Effects of Rhodymeniales on lifestyle-related diseases and brain function

Effects of Rhodymeniales on lifestyle-related diseases and brain function - Effects of Rhodymeniales on lifestyle-related diseases and brain function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000023918
Enrollment
20
Registered
2016-09-04
Start date
2016-09-05
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Impaired glucose tolerance

Interventions

Administration of Rhodymeniales(2g/day) for 8 weeks

Sponsors

Hokkaido University Graduate School
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1)Participants who were 20-year-old or older, and younger than 60-year-old at the time of obtaining informed consent 2)Participants diagnosed as impaired fasting glucose or impaired glucose tolerance by oral glucose tolerance test 3)Participants who can visit the medical institution according to schedule 4)Participants who are able to understand the study and willing to provide written informed consent

Exclusion criteria

Exclusion criteria: 1)Participants in pregnancy, lactation and scheduled pregnancy period 2)Participants who have made a blood donation within 2 (component blood donation), 4 (200mL), or 12 (400mL) weeks 3)Participants who are attending other studies or attended other studies within past 4 weeks 4)Participants with present heart, liver, kidney or thyroid disorders 5)Participants with a history of cardiac disorder 6)Participants with diabetes 7)Participants with allergy to the study foods 8)Participants who have been felt ill by blood collection 9)Participants with heavy use of alcohol 10)Participants with heavy smoking 11)Participants with irregular eating habits 12)Participants who are taking drugs, foods for specified health use or functional foods which could affect this study 13)Participants with a history of receiving a gastrointestinal surgery 14)Participants who are deemed to be unsuitable by the investigator

Design outcomes

Primary

MeasureTime frame
1)Fasting plasma glucose 2)The plasma glucose levels and the area under the curve for glucose during oral glucose tolerance test

Countries

Japan

Contacts

Public ContactAkinobu Nakamura

Hokkaido University Graduate School Division of Rheumatology, Endocrinology and Nephrology

akinbo@huhp.hokudai.ac.jp011-706-5915

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026